Andere talen AbCellera Biologics Inc.

Aandelen

ABCL

CA00288U1066

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,77 ^USD	-1,82%		-5,04%	-33,98%

11/03	AbCellera, Biogen werken samen om behandelingen voor neurologische ziekten te ontdekken	MT
11/03	AbCellera gaat samenwerken met Biogen om therapeutische antilichamen te ontdekken voor neurologische aandoeningen	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

AbCellera Biologics : Corporate Overview	09/04
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024	08/04
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024	03/04
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024	19/03
AbCellera, Biogen Collaborate to Discover Treatments for Neurological Diseases	11/03
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions	11/03
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions	11/03
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024	05/03
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024	05/03
AbCellera Announces Resignation of Board Member	26/02
AbCellera Announces Resignation of Board Member	23/02
AbCellera Biologics Inc. Announces Board Changes	23/02
AbCellera to Present at Upcoming Investor Conferences in March	23/02
AbCellera Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
Earnings Flash (ABCL) ABCELLERA BIOLOGICS Reports Fiscal 2023 Revenue $38M	20/02
AbCellera Reports Full Year 2023 Business Results	20/02
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024	23/01
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024	20/12
Cutting-edge antibody therapy firm, AbCellera, to lay off 10 per cent of workforce	29/11
Abcellera Biologics, Inc. Announces Reorganization	28/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen AbCellera Biologics Inc.

Aandelen

ABCL

CA00288U1066

Andere talen

Filters